|
KRASstatus*
| |
Median OS
| | |
|---|
|
Tumor/Plasma
|
No.
|
(mo)
|
95% Cl
|
Pvalue
|
|---|
|
Negative/Negative
|
113
|
21.0
|
19.226-22.774
|
0.008
|
|
Discordant
|
65
|
16.9
|
14.184-19.616
| |
|
Positive/Positive
|
64
|
15.4
|
14.270-16.530
| |
- *KRAS status was categorized as: negative, mutation-negative tumor and matched plasma samples; discordant, discordant KRAS status in tumor and matched plasma samples; positive, mutation-positive tumor tissue and matched plasma samples.
- CI, confidence interval; mo, month; OS, overall survival; PNA-PCR, peptide-nucleic-acid-mediated polymerase chain reaction clamping.
